Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NVCTNVCT
10 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in NUVECTIS PHARMA INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 57,133 shares of NVCT (NUVECTIS PHARMA INC), worth $1.1M as of 2026-Q2. The position was increased (+15.1% shares). NVCT represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$1.1M

Current Shares

57,133

Total Value Change

+$763,296

Total Shares Change

+39,138

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
57,133
+15.1%
$1.1M0.0%$18.39
29
2026-Q1
Increased
49,645
+12.8%
$383,7560.0%$8.71
27
2025-Q4
Increased
44,022
+15.9%
$332,3660.0%$7.38
27
2025-Q3
Unchanged
37,982
0.0%
$228,6520.0%$5.92
0
2025-Q2
New
37,982
-
$283,7260.0%$7.55
36
2024-Q2
Exited
0
-100.0%
$00.0%$6.33
0
2024-Q1
Unchanged
19,920
0.0%
$163,3440.0%$8.20
0
2023-Q4
Unchanged
19,920
0.0%
$166,1330.0%$8.34
0
2023-Q3
Increased
19,920
+10.7%
$256,7690.0%$12.89
26
2023-Q2
New
17,995
-
$287,3800.0%$16.34
32

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used